文献速递肾小球疾病

国际肾活检调查:肾小球疾病频率因地域和种族而异

Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究调查四大洲29家肾病理实验室连续肾活检诊断频率,分析42 603例肾小球疾病诊断。结果显示不同洲肾小球疾病亚型频率差异显著,且相同种族在不同地域频率也不同,提示环境、生活方式及活检政策独立于种族影响疾病流行病学。

要点

  • 北美以糖尿病肾小球硬化和FSGS为主,各占19.1%。
  • 亚洲以IgA肾病(39.5%)和狼疮肾炎(16.8%)为主。
  • 相同种族在不同地域的肾小球疾病频率存在显著差异。

核心结论

  • 肾小球疾病频率因洲际而异,即使种族/族裔相同也存在差异。
  • 地域环境、生活方式及局部活检政策可能独立于种族影响肾小球疾病流行病学。

研究设计与样本

  • 调查四大洲29家肾病理实验室,采用标准化数据收集表。
  • 获取各中心近期连续肾活检诊断频率及人口学摘要,共60 340例诊断,其中42 603例肾小球疾病诊断。

主要发现

  • 北美以糖尿病肾小球硬化(19.1%)和FSGS(19.1%)为主;拉丁美洲以狼疮肾炎(38.1%)和FSGS(15.8%)为主;欧洲以IgA肾病(22.1%)和FSGS(14.9%)为主;亚洲以IgA肾病(39.5%)和狼疮肾炎(16.8%)为主。
  • 北美拉丁裔较拉丁美洲拉丁裔糖尿病肾小球硬化(17.4% vs 4.3%,P<0.001)和FSGS(17.3% vs 11.8%,P<0.001)更频繁,狼疮肾炎更少(15.8% vs 45.6%,P<0.001)。
  • 北美亚裔较亚洲亚裔FSGS更频繁(13.1% vs 7.1%,P<0.001),IgA肾病更少(27.4% vs 40.5%,P<0.001)。
  • 北美白人较欧洲白人FSGS(18.9% vs 13.5%,P<0.001)和糖尿病肾小球硬化(18.7% vs 6.5%,P<0.001)更频繁,IgA肾病更少(14.4% vs 25.4%,P<0.001)。

临床怎么用

  • 临床评估肾小球疾病时需考虑地域和种族差异,不能直接套用其他地区流行病学数据。
  • 活检政策差异可能影响疾病频率统计,解读流行病学数据时需注意来源背景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Large-scale studies comparing glomerular disease frequencies across continents are lacking. METHODS: We surveyed 29 nephropathology laboratories in four continents using a standardized data collection form. We obtained recent consecutive kidney biopsy diagnosis frequencies at each center and summary demographics for each diagnosis. This report focuses on glomerular disease frequencies by region and race/ethnicity. RESULTS: Among 42 603 glomerular disease diagnoses reported (median age 47 years, 52% male, 57% white), from a total of 60 340 diagnoses, glomerular disease subtype frequencies differed considerably by continent. Diabetic glomerulosclerosis (GS; 19.1%) and focal segmental glomerulosclerosis (FSGS; 19.1%) predominated in North America; lupus nephritis (38.1%) and FSGS (15.8%) predominated in Latin America; IgA nephropathy (IgAN; 22.1%) and FSGS (14.9%) predominated in Europe; and IgAN (39.5%) and lupus nephritis (16.8%) predominated in Asia. After stratifying by race, diabetic GS (17.4% versus 4.3%, P < 0.001) and FSGS (17.3% versus 11.8%, P < 0.001) were more, and lupus nephritis less (15.8% versus 45.6%, P < 0.001), frequent among Latinos in North versus Latin America; FSGS was more (13.1% versus 7.1%, P < 0.001), and IgAN less (27.4% versus 40.5%, P < 0.001), frequent among Asians in North America versus Asia; and FSGS (18.9% versus 13.5%, P < 0.001) and diabetic GS (18.7% versus 6.5%, P < 0.001) were more, and IgAN less (14.4% versus 25.4%, P < 0.001), frequent among whites in North America versus Europe. CONCLUSIONS: We determined that glomerular disease frequencies differed by continent, even among patients of similar race/ethnicity. Regional environmental and lifestyle factors, and local biopsy policies, might influence glomerular disease epidemiology independently of race/ethnicity.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. O'Shaughnessy MM, Hogan SL, Thompson BD, et al. Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transplant. 2018. PMID: 29106637. doi:10.1093/ndt/gfx189

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。